Marker Therapeutics, Inc. (MRKR) NASDAQ

0.92

+0.031(+3.48%)

Updated at November 14 04:00PM

Currency In USD

Valuation

Market Cap27.93M
Enterprise Value8.74M
P/E Ratio-1.08
PEG Ratio-0.11
Price/Sales Ratio2.12
Price/Book Ratio0.84
Enterprise/Revenue-1.62
Enterprise/EBITDA0.94

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-3.05
Operating Margin-3.17

Management Effectiveness

Return On Assets-0.66
Return On Equity-0.92

Income Statement

Revenue6.59M
Revenue/Share0.28
Gross Profit-6.88M
EBITDA-4.53M
Net Income-10.73M
Diluted EPS-1.19

Balance Sheet

Total Cash17.59M
Total Cash/Share1.05
Total Debt0
Total Debt/Equity0
Current Ratio6.5
Book Value Per Share1.1

Price History

52-Week Change-69.93
52-Week High5.95
52-Week Low0.81
Moving Average 50 Days0.96
Moving Average 200 Days1.27

Statistics

Average Volume1.01M
Shares Outstanding10.8M
% Held by Institutions2.33

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateJanuary 27, 2023